Propionic Acid

Propionic Acid

SCHEMBL4155220

CCC(=O)O.N#Cc1ccc(-c2ccc3[nH]c(=O)c4[nH]ccc4c3c2)cc1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FASN P49327 2/20 0.41
PADI4 Q9UM07 1/20 0.39
GSK3B P49841 1/20 0.39
PIM1 P11309 1/20 0.38
PIM3 Q86V86 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
CSF1R P07333 4/20 0.38
KIT P10721 1/20 0.38
FLT3 P36888 1/20 0.38
AR P10275 1/20 0.38
MAP2 P11137 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
XDH P47989 1/20 0.36
AURKA O14965 1/20 0.36
TPX2 Q9ULW0 1/20 0.36
MMP2 P08253 1/20 0.36
GRIK1 P39086 1/20 0.35
GRIK2 Q13002 1/20 0.35
GRIK3 Q13003 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4160179 0.92 BRD4 (0.46) FASNCSF1RARXDHBRD4
Propionic Acid SCHEMBL4153840 0.87 PIM1 (0.44) GSK3BPIM1CSF1RMEN1KMT2A
Propionic Acid SCHEMBL4162600 0.85 PARP1 (0.38) GSK3BPIM1PIM2MEN1KMT2A
Propionic Acid SCHEMBL4160151 0.84 PTGS2 (0.48) GSK3B
Propionic Acid SCHEMBL4167721 0.83 PRKAG1 (0.46) GSK3BMMP2
Propionic Acid SCHEMBL4165408 0.83 GABRA1 (0.39) FASNPIM1PIM3PIM2AR
Propionic Acid SCHEMBL4166173 0.82 GRIN2D (0.41) GSK3BPIM1PIM2MEN1KMT2A
Propionic Acid SCHEMBL4155190 0.82 PTGS2 (0.40) GRIK1GRIK2GRIK3BRD4
Propionic Acid SCHEMBL4157572 0.81 GRIN2D (0.40) GSK3BPIM1MEN1KMT2AGRIK1
Propionic Acid SCHEMBL4160296 0.81 GRM5 (0.44) FASNPIM1MMP2GRIK2GRIK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 FASN 2527/4885PADI4 2226/4885GSK3B 291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.